$0.2055
-0.00350-1.67%
At close: -
$0.2022
-0.00330-1.61%
After Hours: 7:37 PM EDT
Comments
Loading...
Latest news for Syros Pharmaceuticals (NASDAQ:SYRS) Stock
Syros Pharmaceuticals Stock (NASDAQ: SYRS)
Categories: All
Tuesday, November 19, 2024
Monday, November 18, 2024
Wednesday, November 13, 2024
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- S&P 500 Tops 6,000; Rumble Shares Slide After Q3 Results
- Dow Jumps Over 150 Points; CyberArk Posts Upbeat Earnings
- Syros Pharmaceuticals Stock Sinks As Pivotal Blood Cancer Trial Flunks, Triggers Loan Default
- US Stocks Mixed; Inflation Rate Increases In October
- Syros Pharmaceuticals shares are trading lowe...
- TD Cowen Downgrades Syros Pharmaceuticals to ...
- HC Wainwright & Co. Downgrades Syros Pharmace...
- JMP Securities Downgrades Syros Pharmaceutica...
- Brookline Capital Downgrades Syros Pharmaceut...
- Why Rocket Lab Shares Are Trading Higher By Around 29%; Here Are 20 Stocks Moving Premarket
Tuesday, November 12, 2024
Friday, November 01, 2024
Thursday, October 31, 2024
Tuesday, August 13, 2024
- Crude Oil Down 2%; Paysafe Shares Surge After Q2 Results
- S&P 500 Gains 1%; Home Depot Earnings Top Views
- Piper Sandler Reiterates Overweight on Syros ...
- Nasdaq Surges 200 Points; US Producer Prices Increase 0.1% In July
- Cancer-Focused Syros Pharmaceuticals Stops Mid-Stage Leukemia Combo Therapy Study, Cites Disappointing Unexpected Outcome
- JMP Securities Maintains Market Outperform on...
- HC Wainwright & Co. Maintains Buy on Syros Ph...
- Syros Pharmaceuticals shares are trading lowe...
- Why Rumble Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket